TAZAROTENE
| Brand name | ARAZLO |
|---|---|
| Active ingredient | TAZAROTENE |
| Strength | 0.045% |
| Dosage form | LOTION |
| Route | TOPICAL |
| Modality | Small molecule |
| FDA approval | December 2019 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 11311482 | May 2038 | use U-2368 |
| 12128137 | May 2038 | product |
| 11679116 | June 2036 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.